EGFR and cervical cancer: HPV oncoproteins, E5 and E6, have been shown to regulate the activation and augmentation of epidermal growth factor receptor (EGFR), which is associated with poor prognosis in cervical cancer (Akerman et al., 2001; Iida et al., 2011; Ilahi and Bhatti, 2020).